Table 5.
Seondary analysis
| Variable | Cases | Controls | Adjusted ORa | 95% CIb | P value |
|---|---|---|---|---|---|
| Age (SD)c |
45.49 (11.39) |
44.31 (11.18) |
|
|
|
| Genderc |
|
|
|
|
|
| Female |
109 (55.9%) |
351 (57.8%) |
|
|
|
| Male |
86 (44.1%) |
256 (42.2%) |
|
|
|
| PPId use |
15 (7.7%) |
23 (3.8%) |
2.25 |
(1.09-4.62) |
0.027 |
| NSAIDe use |
58 (29.7%) |
125 (20.6%) |
1.36 |
(0.91-2.03) |
0.131 |
| Antibiotic use |
45 (23.1%) |
48 (7.9%) |
3.24 |
(2.06-5.10) |
<0.001 |
| Diuretic use | 12 (6.2%) | 8 (1.3%) | 5.08 | (1.95-13.21) | <0.001 |
aOR odds ratio.
bCI confidence interval.
c Cases and controls were matched on age and gender so those variables were not compared statistically.
dPPI proton pump inhibitor.
eNSAID nonsteroidal anti-inflammatory drugs.